Efficacy and Safety of Combined PD-1 Inhibitor With Induction Chemotherapy Followed by IMRT Plus Nimotuzumab in Locally Advanced Nasopharyngeal Carcinoma: A Retrospective Analysis
The combination of PD-1 inhibitors with IC, followed by nimotuzumab and IMRT, shows promising efficacy and safety in the treatment of LANPC.
Authors
- Xiaopeng Huang (ORCID: https://orcid.org/0000-0002-5106-5176)
- Shuai Zhang (ORCID: https://orcid.org/0000-0002-9818-7760)
- Jiawei Chen (ORCID: https://orcid.org/0000-0001-5383-1359)
- Kebin Chen
Institutions
- Hainan General Hospital (CN)
- Hainan Medical University (CN)
Publication Details
- Journal
- OncoTargets and Therapy
- Published
- 2025-02-01
- DOI
- https://doi.org/10.2147/ott.s503674
- Citations
- 2
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 2.09